A Phase I, Randomized, Double- Blind, Placebo- Controlled, Single-center Study, to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451 Following Single Ascending Oral Dose Administration in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 29 Jul 2011
At a glance
- Drugs AZD 4451 (Primary)
- Indications Depression
- Focus Adverse reactions; Pharmacokinetics
- 29 Jul 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 29 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2010 Actual initiation date (August 2010) added as reported by ClinicalTrials.gov.